Screener
GeneDx Holdings WGS Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001818331-26-000041
| Line item | Three months ended March 31, 2026 | 2025 |
|---|---|---|
| Loss from operations | (57,471) | (4,551) |
| Non-operating (expenses) income, net | ||
| Change in fair value of financial liabilities | 2,540 | (1,100) |
| Interest expense, net | (717) | (640) |
| Loss on extinguishment of debt | (6,565) | — |
| Other (expense) income, net | (206) | 209 |
| Total non-operating expense, net | (4,948) | (1,531) |
| Loss before income taxes | (62,419) | (6,082) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is GeneDx Holdings's interest expense?
- GeneDx Holdings (WGS) reported interest expense of -$717K in Q1 2026.
- How has GeneDx Holdings's interest expense changed year-over-year?
- GeneDx Holdings's interest expense decreased by 12.0% year-over-year, from -$640K to -$717K.
- What is the long-term trend for GeneDx Holdings's interest expense?
- Over 3 years (2021 to 2025), GeneDx Holdings's interest expense has grown at a -3.6% compound annual growth rate (CAGR), from $2.84M to -$2.54M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about GeneDx Holdings's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude